Home » Authors » Don Long

Articles by Don Long

Lab tubes receive 'pachinko' payoff from 'coil-on-a-chip'

Feb. 14, 2005

Cytyc grows in women's health via $160 million Proxima buy

Feb. 11, 2005

Deals roundup: Invitrogen adding Dynal and 'bead' technology for $380M

Feb. 10, 2005

Invitrogen Adding Dynal Biotech, Its 'Bead' Technology For $380M

Feb. 9, 2005

Invitrogen adding Dynal and 'bead' technology for $380M

Feb. 9, 2005

Invitrogen Adding Dynal Biotech, Its 'Bead' Technology For $380M

Feb. 9, 2005

CMS broadens need, codes for power wheelchairs, scooters

Feb. 7, 2005

MDMA: New report challenges GPOs' unsubstantiated claims'

Feb. 4, 2005

Cerus, Baxter re-do Intercept pact, settle dispute over loan

Feb. 4, 2005

Molecular tests ready to extend entire spectrum of diagnostics

Feb. 3, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.